66
Participants
Start Date
September 30, 2009
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
budesonide
400 yg x 1
terbutaline
0.4 mg as-needed
budesonide/formoterol
160/4.5 yg as-needed
Research Site, Oslo
Research Site, Trondheim
Research Site, Gothenburg
Research Site, Huddinge
Research Site, Linköping
Research Site, Luleå
Research Site, Lund
Research Site, Skene
Research Site, Stockholm
Research Site, Uppsala
Lead Sponsor
AstraZeneca
INDUSTRY